Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer
Dregamine (1), a major monoterpene indole alkaloid isolated from Tabernaemontana elegans, was submitted to chemical transformation of the ketone function, yielding 19 azines (3-21) and 11 semicarbazones (22-32) bearing aliphatic or aromatic substituents. Their structures were assigned mainly by 1D a...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2021
|
| Sorozat: | PHARMACEUTICALS
14 No. 9 |
| Tárgyszavak: | |
| doi: | 10.3390/ph14090862 |
| mtmt: | 32287706 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/27790 |
| LEADER | 02425nab a2200277 i 4500 | ||
|---|---|---|---|
| 001 | publ27790 | ||
| 005 | 20230704085004.0 | ||
| 008 | 230704s2021 hu o 0|| Angol d | ||
| 022 | |a 1424-8247 | ||
| 024 | 7 | |a 10.3390/ph14090862 |2 doi | |
| 024 | 7 | |a 32287706 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a Angol | ||
| 100 | 1 | |a Cardoso David | |
| 245 | 1 | 0 | |a Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer |h [elektronikus dokumentum] / |c Cardoso David |
| 260 | |c 2021 | ||
| 300 | |a 31 | ||
| 490 | 0 | |a PHARMACEUTICALS |v 14 No. 9 | |
| 520 | 3 | |a Dregamine (1), a major monoterpene indole alkaloid isolated from Tabernaemontana elegans, was submitted to chemical transformation of the ketone function, yielding 19 azines (3-21) and 11 semicarbazones (22-32) bearing aliphatic or aromatic substituents. Their structures were assigned mainly by 1D and 2D NMR (COSY, HMQC, and HMBC) experiments. Compounds 3-32 were evaluated as multidrug resistance (MDR) reversers through functional and chemosensitivity assays in a human ABCB1-transfected mouse T-lymphoma cell model, overexpressing P-glycoprotein. A significant increase of P-gp inhibitory activity was observed for most derivatives, mainly those containing azine moieties with aromatic substituents. Compounds with trimethoxyphenyl (17) or naphthyl motifs (18, 19) were among the most active, exhibiting strong inhibition at 0.2 mu M. Moreover, most of the derivatives showed selective antiproliferative effects toward resistant cells, having a collateral sensitivity effect. In drug combination assays, all compounds showed to interact synergistically with doxorubicin. Selected compounds (12, 17, 18, 20, and 29) were evaluated in the ATPase activity assay, in which all compounds but 12 behaved as inhibitors. To gather further insights on drug-receptor interactions, in silico studies were also addressed. A QSAR model allowed us to deduce that compounds bearing bulky and lipophilic substituents were stronger P-gp inhibitors. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Szemerédi Nikoletta |e aut |
| 700 | 0 | 1 | |a Spengler Gabriella |e aut |
| 700 | 0 | 1 | |a Mulhovo Silva |e aut |
| 700 | 0 | 2 | |a dos Santos Daniel |e aut |
| 700 | 0 | 2 | |a Ferreira Maria-José U. |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/27790/1/32287706_32287706_pharmaceuticals-14-00862-v2-compressed.pdf |z Dokumentum-elérés |